Cortellis Supply Chain Network | Clarivate

Cortellis Supply Chain Network is Clarivate’s premium data-as-a-service platform that maps and monitors the global pharmaceutical ingredient, supplier and manufacturing network. Delivered through annual enterprise subscriptions (five- to seven-figure USD), the cloud-only dashboard provides real-time supplier alerts, regulatory filings, capacity forecasts and ESG risk scores for APIs, excipients, biologics and packaging components. There is no retail channel; licenses are sold directly to qualified life-science organizations by Clarivate’s specialist sales team. The service is built on the former Newport and Integrity supplier databases merged with Clarivate’s proprietary drug pipeline intelligence, giving it the only single registry that links every approved ingredient to 25,000+ suppliers, 70,000+ facilities and 120+ regulatory agencies. Notable modules include “Supplier Red-Flag Monitor,” which pushes 24-hour advance warnings of inspections, shortages or sanctions, and “Green Chemistry Index,” which benchmarks carbon and waste metrics across 900+ active sites. These tools are referenced by FDA and EMA shortage reports. Primary buyers are global procurement, quality and CMC directors at Big Pharma, generic houses, CDMOs and large generics who must qualify secondary sources, defend continuity-of-supply filings and meet ESG disclosure rules. The brand appeals to data-driven operators who treat regulatory resilience and sustainability metrics as hard ROI, not marketing. Cortellis competes with boutique supply-chain consultancies, generic regulatory databases and in-house Excel trackers. It differentiates by embedding live regulatory feeds, predictive analytics and ESG benchmarking inside the same workflow already used for pipeline and patents, eliminating the need for multiple standalone tools.